Morning Stock Movers: Novovax, Moderna, Square

The video discusses the current market trends, highlighting Novak's share decline due to delays in COVID-19 application submissions. Moderna's stock is rising, driven by vaccine optimism and new data. Kroger's earnings are anticipated, with the company showing strong year-to-date performance. Affirm's earnings report shows significant growth, boosted by its partnership with Amazon, affecting other payment stocks like MasterCard and Square.

What was the reason for the decline in Novak's shares?

• Management changes

• Poor financial results

• Delay in COVID-19 application submissions

• Increased competition

Why did Moderna's shares rise?

• New product launch

• Reduction in production costs

• Acquisition of a competitor

• Optimism around booster shots and new data

What challenge is Kroger facing despite its strong performance?

• Declining customer base

• Tough comparisons to previous pandemic-related gains

• Increased operational costs

• Supply chain issues

What is Affirm's projected gross merchandise volume for the fiscal year?

• $13 billion

• $12.5 to $12.75 billion

• $11 billion

• $10 billion

Which companies were positively impacted by Affirm's earnings report?

• American Express and Discover

• MasterCard and Square

• Stripe and Payoneer

• Visa and PayPal